Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8227240 | International Journal of Radiation Oncology*Biology*Physics | 2012 | 7 Pages |
Abstract
High-dose and extended involved-field IMRT for patients with early-stage nasal NK/T-cell lymphoma showed favorable locoregional control, overall survival, and progression-free survival, with mild toxicity. The dose constraints of IMRT for the parotid glands can be limited to <20 Gy in these patients.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Hua M.D., Ye-Xiong M.D., Wei-Hu M.D., Jing M.D., Jian-Rong M.D., Shu-Lian M.D., Yue-Ping M.D., Yong-Wen M.D., Zhao-Yang M.D., Qing-Feng M.D., Hui M.D., Shu-Nan M.D., Xin-Fan M.D., Zi-Hao M.D.,